Gene · 4973
Papers4,129
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 4,129
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biomarker Development in Cardiology: Reviewing the Past to Inform the Future. | Cells | 2022 | 35159397 | PubTator, text mining | PubMed |
| Chemokines as Regulators of Neutrophils: Focus on Tumors, Therapeutic Targeting, and Immunotherapy. | Cancers (Basel) | 2022 | 35158948 | PubTator, text mining | PubMed |
| Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective. | Cancers (Basel) | 2022 | 35158779 | PubTator, text mining | PubMed |
| Association of Angiogenesis Gene Expression With Cancer Prognosis and Immunotherapy Efficacy. | Front Cell Dev Biol | 2022 | 35155426 | PubTator, text mining | PubMed |
| Identification of Key Pathways and Establishment of a Seven-Gene Prognostic Signature in Cervical Cancer. | J Oncol | 2022 | 35154316 | PubTator, text mining | PubMed |
| High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure. | Intensive Care Med Exp | 2022 | 35146585 | PubTator, text mining | PubMed |
| Low-Density Granulocytes in Immune-Mediated Inflammatory Diseases. | J Immunol Res | 2022 | 35141336 | PubTator, text mining | PubMed |
| Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease. | Alzheimers Res Ther | 2022 | 35139885 | PubTator, text mining | PubMed |
| Controlled human exposure to diesel exhaust: results illuminate health effects of traffic-related air pollution and inform future directions. | Part Fibre Toxicol | 2022 | 35139881 | PubTator, text mining | PubMed |
| Hypertriglyceridemia: A Neglected Risk Factor for Ischemic Stroke? | J Stroke | 2022 | 35135057 | PubTator, text mining | PubMed |
| Transcriptomic Analysis Reveals the Messenger RNAs Responsible for the Progression of Alcoholic Cirrhosis. | Hepatol Commun | 2022 | 35134262 | PubTator, text mining | PubMed |
| Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35130611 | PubTator, text mining | PubMed |
| Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy. | Pharmacol Ther | 2022 | 35122833 | PubTator, text mining | PubMed |
| Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome. | J Renin Angiotensin Aldosterone Syst | 2022 | 35111237 | PubTator, text mining | PubMed |
| Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? | Nat Rev Cardiol | 2022 | 35102320 | PubTator, text mining | PubMed |
| Indirect mediators of systemic health outcomes following nanoparticle inhalation exposure. | Pharmacol Ther | 2022 | 35085604 | PubTator, text mining | PubMed |
| SCARF1-Induced Efferocytosis Plays an Immunomodulatory Role in Humans, and Autoantibodies Targeting SCARF1 Are Produced in Patients with Systemic Lupus Erythematosus. | J Immunol | 2022 | 35082161 | PubTator, text mining | PubMed |
| Identifying changes in immune cells and constructing prognostic models using immune-related genes in post-burn immunosuppression. | PeerJ | 2022 | 35070500 | PubTator, text mining | PubMed |
| CBX2 and EZH2 cooperatively promote the growth and metastasis of lung adenocarcinoma. | Mol Ther Nucleic Acids | 2022 | 35070495 | PubTator, text mining | PubMed |
| Lectin-type oxidized LDL receptor 1 modulates matrix metalloproteinase 2 production in peri-implantitis. | Exp Ther Med | 2022 | 35069852 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4973/papers?page=60